Skip to main content
. 2021 Jun 5;21:263. doi: 10.1186/s12887-021-02746-5

Table 2.

Comparison of risk factors according to asthma outcome in wheezing children

Variables Study group (43)
Non-asthma Asthma p value
Total n(%) 17(39.5) 26(60.5)
Sex n(%)
 Male 10(58.8) 19(73.1) 0.329*
 Female 7 (41.2) 7(26.9)
Age group n(%)
 ≤3 years old 10(58.8) 11(42.3) 0.289*
 3-5 years old 7(41.2) 15(57.7)
Systemic glucocorticoid n(%)
 Yes 6(35.3) 4(15.4) 0.254*
 No 11(64.7) 22(84.6)
Wheezing frequency n(%)
 <4 times 13(76.5) 8(30.8) 0.003*
 ≥4 times 4(23.5) 18(69.2)
Age when first wheezing n(%)
 ≤3 years old 17(100.0) 21(80.8) 0.139*
 3-5years old 0(0.0) 5(19.2)
Duration of wheezing onset to enroll, median (IQR)(years) 0.9(0.0,1.5) 2.1(0.4, 4.8) 0.052**
Allergic rhinitis n(%) 7(41.2) 15(57.7) 0.289*
Atopic dermatitis n(%) 9(52.9) 17(65.4) 0.415*
Family allergic diseases 6(35.3) 17(65.4) 0.053*
Asthma prediction index n(%) 9(52.9) 23(88.5) 0.024***
Inhalant allergen sIgE n(%) 8(47.1) 16(69.6) 0.151*
Food allergen sIgE n(%) 8(47.1) 15(65.2) 0.251*
Total IgE(IU/ml) 46(8.6, 204.0) 192.5(60.9, 805.0) 0.055**

CD4+CCR6+CRTh2+cells

mean±SD(%)

0.8±0.6 1.6±0.8 <0.001**

*: Pearson Chi-Square; **: Mann-Whitney Rank sum test; **: t-test; ***: Continuity Correction